Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from NeOnc Technologies Holdings, Inc. ( (NTHI) ) is now available.
On July 1, 2022, NeOnc Technologies, Inc., a subsidiary of NeOnc Technologies Holdings, Inc., entered into an Intellectual Property License and Supply Agreement with Fox Infused, LLC, under which NeOnc agreed to supply certain products and license specific patents. NeOnc terminated the agreement on April 25, 2023, prompting Fox Infused to file a complaint on June 6, 2023, in the Central District of California, seek a temporary restraining order, and later pursue arbitration after the court denied the restraining order and dismissed the case without prejudice.
Following arbitration and settlement discussions, the parties agreed that NeOnc would pay Fox Infused $600,000 by the earlier of five business days after NeOnc’s initial public offering closing or March 31, 2024. On February 27, 2026, NeOnc paid Fox Infused a total of $737,920.77, including $137,920.77 in interest, thereby fully resolving the dispute and eliminating the related legal overhang for the company and its stakeholders.
The most recent analyst rating on (NTHI) stock is a Hold with a $10.00 price target. To see the full list of analyst forecasts on NeOnc Technologies Holdings, Inc. stock, see the NTHI Stock Forecast page.
Spark’s Take on NTHI Stock
According to Spark, TipRanks’ AI Analyst, NTHI is a Neutral.
The score is held back primarily by weak financial fundamentals (large losses, negative equity, and heavier cash burn), partially offset by constructive technicals with the stock trading above key moving averages and moderate momentum. Valuation is also a drag due to the negative P/E and lack of dividend yield.
To see Spark’s full report on NTHI stock, click here.
More about NeOnc Technologies Holdings, Inc.
NeOnc Technologies Holdings, Inc., through its wholly owned subsidiary NeOnc Technologies, Inc., operates in the medical and biopharmaceutical technology sector, developing and supplying specialized products based on its patented technologies. The company’s business model includes licensing its intellectual property and supplying related products to partners, reflecting a strategy focused on monetizing its patent portfolio in targeted healthcare and technology markets.
Average Trading Volume: 61,005
Technical Sentiment Signal: Strong Buy
Current Market Cap: $208.3M
See more data about NTHI stock on TipRanks’ Stock Analysis page.